Research and Education Component
研究和教育部分
基本信息
- 批准号:10188390
- 负责人:
- 金额:$ 18.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-15 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaBasic ScienceBiologyBiomedical EngineeringBiometryCaliforniaClinicalClinical ResearchClinical TrialsCognitionCollaborationsCommunitiesData ScienceDementiaDevelopmentDisciplineDiseaseDisease modelDown SyndromeEcosystemEducationEducational CurriculumEducational workshopEnsureEpidemiologyEvaluationExposure toFacultyFellowship ProgramFoundationsGrantGrowthHomeHuman Subject ResearchImmersionInternationalKnowledgeLeadMachine LearningMentorsMentorshipModalityNerve DegenerationNeurobiologyOutcome MeasurePositioning AttributeProcessRecommendationRecruitment ActivityReportingResearchResearch DesignResearch PersonnelResearch TrainingResourcesScienceScientistSpecial PopulationStructureSystems BiologyTalentsTimeTrainingTraining ActivityTraining ProgramsTraining and InfrastructureUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesWritingbench to bedsidecareer life balancecohorteducation researchexperienceinnovationinterdisciplinary approachmeetingsmembermultidisciplinaryneuroimagingneuropathologypreventprogramsrecruitresponsible research conductskillsskills trainingsuccesssymposiumtraining opportunity
项目摘要
Research Education Component
Project Summary/Abstract
The Research Education Component (REC) for the UCI ADRC will provide state of the art training that
contributes to the development of a workforce with expertise in Alzheimer disease and related dementias
(ADRD). The REC will identify trainees and tailor personalized curricula that leverage training opportunities
capitalizing on the full AD ecosystem at UCI. Training will be provide to 3-4 junior investigators (basic science
to clinicians) from multidisciplinary backgrounds and leveraging the full and unique resources of the UCI
ADRC. Our REC will also practice inclusive excellence and values diversity. Training will include structured
workshops and seminars that will provide exposure to the responsible conduct of research and professional
skills such as grant writing, networking, work-life balance, etc. Critically important, one-on-one mentoring
through ADRC faculty will provide immersion in multidisciplinary and team science approaches to the study of
ADRD and the importance of collaboration, innovation and education. The REC will provide a framework for
training, mentorship and protected and dedicated time for ADRC training activities. Successful trainees are
expected to continue research in ADRD, to facilitate and accelerate possible cures for AD and related
dementias and be fully engaged in the ADRC research community.
研究及教育组成部分
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth Head其他文献
Elizabeth Head的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth Head', 18)}}的其他基金
T21RS Meeting June 2022 Long Beach, California
T21RS 会议 2022 年 6 月 加利福尼亚州长滩
- 批准号:
10469127 - 财政年份:2022
- 资助金额:
$ 18.62万 - 项目类别:
Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease
他克莫司在阿尔茨海默病犬模型中的临床前评价
- 批准号:
10446042 - 财政年份:2017
- 资助金额:
$ 18.62万 - 项目类别:
Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease
他克莫司在阿尔茨海默病犬模型中的临床前评价
- 批准号:
10198086 - 财政年份:2017
- 资助金额:
$ 18.62万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 18.62万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 18.62万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 18.62万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 18.62万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 18.62万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 18.62万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 18.62万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 18.62万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 18.62万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 18.62万 - 项目类别: